Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...
On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...
CAR T-cell therapy is an advanced immunotherapy that harnesses the power of a patient’s own immune cells, specifically ...
Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...